Respiratory Tract Infection Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

Respiratory Tract Infection Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

The report on the global respiratory tract infection market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global respiratory tract infection market to grow with a CAGR of 6.4% over the forecast period from 2019-2025. The study on respiratory tract infection market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on respiratory tract infection market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global respiratory tract infection market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global respiratory tract infection market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
Increasing occurrence of respiratory illness
The increase in the elderly population
2) Restraints
The growing frequency of antibiotic resistance and adverse events relating to the consumption of NSAIDs
3) Opportunities
Rapid industrialization in the developing countries leading to increased air and water pollution

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global respiratory tract infection market is segmented on the basis of drugs, disease indication, and distribution channels.

The Global Respiratory Tract Infection Market by Drugs
Antibiotics
Non-steroidal Anti-inflammatory Drugs
Nasal Decongestants
Cough Suppressants
Other Drugs

The Global Respiratory Tract Infection Market by Disease Indication
Upper Respiratory Tract Infection
Lower Respiratory Tract Infection

The Global Respiratory Tract Infection Market by Distribution Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Company Profiles
The companies covered in the report include
Abbott
AstraZeneca
Teva Pharmaceutical Industries Ltd.
AbbVie Inc.
GlaxoSmithKline plc
Pfizer Inc.
Novartis AG
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd
Sanofi S.A.

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the respiratory tract infection market.
2. Complete coverage of all the segments in the respiratory tract infection market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global respiratory tract infection market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Please Note: Single user allows 1 - 5 users.


1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Respiratory Tract Infection Market Highlights
2.2. Respiratory Tract Infection Market Projection
2.3. Respiratory Tract Infection Market Regional Highlights
3. Global Respiratory Tract Infection Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Drugs
3.4.2. IGR-Growth Matrix Analysis by Disease Indication
3.4.3. IGR-Growth Matrix Analysis by Distribution Channels
3.4.4. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Respiratory Tract Infection Market
4. Respiratory Tract Infection Market Macro Indicator Analysis
5. Global Respiratory Tract Infection Market by Drugs
5.1. Antibiotics
5.2. Non-steroidal Anti-inflammatory Drugs
5.3. Nasal Decongestants
5.4. Cough Suppressants
5.5. Other Drugs
6. Global Respiratory Tract Infection Market by Disease Indication
6.1. Upper Respiratory Tract Infection
6.2. Lower Respiratory Tract Infection
7. Global Respiratory Tract Infection Market by Distribution Channels
7.1. Hospital Pharmacies
7.2. Retail Pharmacies
7.3. Online Pharmacies
8. Global Respiratory Tract Infection Market by Region 2019-2025
8.1. North America
8.1.1. North America Respiratory Tract Infection Market by Drugs
8.1.2. North America Respiratory Tract Infection Market by Disease Indication
8.1.3. North America Respiratory Tract Infection Market by Distribution Channels
8.1.4. North America Respiratory Tract Infection Market by Country
8.2. Europe
8.2.1. Europe Respiratory Tract Infection Market by Drugs
8.2.2. Europe Respiratory Tract Infection Market by Disease Indication
8.2.3. Europe Respiratory Tract Infection Market by Distribution Channels
8.2.4. Europe Respiratory Tract Infection Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Respiratory Tract Infection Market by Drugs
8.3.2. Asia-Pacific Respiratory Tract Infection Market by Disease Indication
8.3.3. Asia-Pacific Respiratory Tract Infection Market by Distribution Channels
8.3.4. Asia-Pacific Respiratory Tract Infection Market by Country
8.4. RoW
8.4.1. RoW Respiratory Tract Infection Market by Drugs
8.4.2. RoW Respiratory Tract Infection Market by Disease Indication
8.4.3. RoW Respiratory Tract Infection Market by Distribution Channels
8.4.4. RoW Respiratory Tract Infection Market by Sub-region
9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Respiratory Tract Infection Market
9.2. Companies Profiles
9.2.1. Abbott
9.2.2. AstraZeneca
9.2.3. Teva Pharmaceutical Industries Ltd.
9.2.4. AbbVie Inc.
9.2.5. GlaxoSmithKline plc
9.2.6. Pfizer Inc.
9.2.7. Novartis AG
9.2.8. Merck & Co., Inc.
9.2.9. F. Hoffmann-La Roche Ltd
9.2.10. Sanofi S.A.
10. Appendix
10.1. Primary Research Findings and Questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook